Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ruixian, Xing"'
Autor:
Yuchen Wu, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Nan Ji, Yuanbo Liu
Publikováno v:
Chinese Neurosurgical Journal, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS relapse of systemic lymphoma. Prognosis of SCNSL is poor and the most
Externí odkaz:
https://doaj.org/article/8b22ce4edf074641a89a0599d51376c3
Autor:
Xuefei Sun, Yuchen Wu, Ruixian Xing, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Chunji Gao, Nan Ji, Yuanbo Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Primary central nervous system lymphoma (PCNSL) remains a disease with poor outcome and high recurrence rate. We retrospectively analyzed the clinical data of 243 immunocompetent patients with PCNSL in Beijing Tiantan Hospital. The median age of PCNS
Externí odkaz:
https://doaj.org/article/21bb7b63e383498bb4bbe5dc0ecd429b
Autor:
Yuchen Wu, Yaming Wang, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Jiayuan Guo, Nan Ji, Shengjun Sun, Yuanbo Liu
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Secondary central nervous system lymphoma (SCNSL) is defined as secondary central nervous system (CNS) involvement in patients with systemic lymphoma. It is considered a profoundly adverse complication with inferior clinical outco
Externí odkaz:
https://doaj.org/article/59c1729753d847068c9c4db5c65ecf4d
Publikováno v:
Experimental Animals. 72:151-163
Autor:
Na Shen, Yaming Wang, Xuefei Sun, Xueyan Bai, Jinglan He, Qu Cui, Jun Qian, Hong Zhu, Yuedan Chen, Ruixian Xing, Qing Liu, Yuchen Wu, Junhong Li, Wenyuan Lai, Shengjun Sun, Nan Ji, Yuanbo Liu
Publikováno v:
Brain and Behavior, Vol 10, Iss 8, Pp n/a-n/a (2020)
Abstract Background It has been indicated that abnormal glucose metabolism mediated by hypoxia‐inducible factor 1α (HIF‐1α) played an essential role in the development of solid tumor. However, there were rare studies about the role of them in p
Externí odkaz:
https://doaj.org/article/d9bbf4b5d97746669c5e333db182e98c
Publikováno v:
Experimental animals.
Stroke, a type of acute cerebrovascular disease, is a global disease with high mortality. Neuronal ischemia and hypoxia are closely related to occurrence and development of cognitive impairment. Transmembrane p24 trafficking protein 10 (TMED10) as a
Publikováno v:
Drug Development Research. 82:969-979
Parkinson's disease (PD) is a disabling neurodegenerative disease mainly caused by degeneration of mesencephalic dopaminergic neurons in the substantia nigra pars compacta (SNpc). The neuroprotective role of Na+ /H+ exchangers isoform-1 (NHE1) inacti
Autor:
Lie Zang, Xue Tian, Xidong Li, Lei Zhang, Jing Dong, Yang Yang, Xuejie Zhang, Xin Mao, Dan Li, Fengjiao Qi, Meiyi Huang, Xueling Yuan, Huiru Wu, Ruixian Xing, Rubo Sui, Bo Yu
Publikováno v:
International journal of biological macromolecules. 192
There are several studies reporting that different plant-based metabolites are potential inhibitors of protein amyloid fibrillation. As chemical features of metabolites can regulate protein aggregation process, in the present in vitro investigation,
Autor:
Bing Li, Junqing Xu, Jingya Wang, Robert Peter Gale, Zefeng Xu, Yajuan Cui, Lin Yang, Ruixian Xing, Xiaofei Ai, Tiejun Qin, Yue Zhang, Peihong Zhang, Zhijian Xiao
Publikováno v:
Haematologica, Vol 99, Iss 11 (2014)
We tested 357 Chinese with primary myelofibrosis for mutations in CALR, JAK2 and MPL. CALR mutations were detected in 76 subjects (21%). There were 24 (32%) type-1 (L367fs*46) and 49 (64%) type-2 (K385fs*47) mutations. Seventy-two of 168 subjects (43
Externí odkaz:
https://doaj.org/article/9496b6e915114c82a7690303da409dc0
Autor:
Xuefei Sun, Yaming Wang, Hong Zhu, Qing Liu, Yuedan Chen, Jun Qian, Junhong Li, Yuanbo Liu, Qu Cui, Ruixian Xing, Xueyan Bai, Wenyuan Lai, Nan Ji, Yuchen Wu, Shengjun Sun
Publikováno v:
Chinese Neurosurgical Journal
Chinese Neurosurgical Journal, Vol 7, Iss 1, Pp 1-8 (2021)
Chinese Neurosurgical Journal, Vol 7, Iss 1, Pp 1-8 (2021)
Background Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS relapse of systemic lymphoma. Prognosis of SCNSL is poor and the most appropri